Post by
pjn0987654321 on Jun 26, 2023 9:23am
RBC's comment
"Our view: We expect the announcement to have a neutral to modestly
positive impact on Chemtrade shares, as the positive news of another
EBITDA guidance increase for 2023 is partially offset by the decision to
put the greenfield ultrapure sulphuric acid development in Arizona on hold
(FEED completed). Due to the growth in the U.S. semiconductor industry,
we expect the company to eventually move forward with the development
when inflationary pressures subside. We maintain our Outperform rating
and $11 price target."